Hemo Organic Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 18, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	70	41	31	35	25	178
Market Cap Growth	113.26%	30.44%	-12.06%	43.66%	-86.16%	251.37%
Enterprise Value	97	57	43	35	25	178
Last Close Price	20.11	11.70	8.97	10.20	7.10	51.30
PE Ratio	-	-	18.97	-	-	-
PS Ratio	7.49	4.36	1.25	156.43	512.66	2603.23
PB Ratio	52.44	30.51	-20.52	-11.21	-48.06	5177.66
P/TBV Ratio	52.44	30.51	-	-	-	5177.66
P/FCF Ratio	-	-	-	-	22.98	-
P/OCF Ratio	-	-	-	-	22.98	-
EV/Sales Ratio	10.42	6.12	1.75	155.31	518.60	2606.88
EV/EBIT Ratio	-	-	169.02	-	-	-
EV/FCF Ratio	-	-	-	-	23.24	-
Debt / Equity Ratio	20.62	20.62	-9.77	-3.92	-0.69	10.21
Debt / FCF Ratio	-	-	-	-	0.33	-
Net Debt / Equity Ratio	20.54	20.54	-9.71	-3.52	1.59	7.52
Net Debt / EBITDA Ratio	-5.48	-5.48	-	-	-	-
Net Debt / FCF Ratio	-1.87	-1.87	-4.07	-0.93	-0.76	-5.83
Asset Turnover	0.20	0.20	0.82	0.03	0.02	0.03
Inventory Turnover	0.97	0.97	-	-	0.10	0.97
Quick Ratio	1.95	1.95	0.90	6.50	0.51	0.34
Current Ratio	2.81	2.81	1.29	6.50	0.56	0.48
Return on Equity (ROE)	-	-	-	-	-	-180.16%
Return on Assets (ROA)	-6.60%	-6.60%	0.53%	-21.02%	-11.70%	-16.47%
Return on Capital Employed (ROCE)	-17.30%	-17.30%	1.90%	-25.70%	341.30%	-161.80%
Earnings Yield	-11.16%	-19.19%	5.27%	-7.47%	-2.22%	-0.35%
FCF Yield	-20.94%	-35.99%	-11.63%	-33.67%	4.35%	-0.03%
Buyback Yield / Dilution	-0.22%	-0.22%	-	-	-	-